Pharmaceutical Contract Manufacturing Market Size, Industry Trends, Share and Forecast 2021-2027
The global pharmaceutical contract manufacturing market is anticipated to grow at a considerable CAGR of around 6.9% during the forecast period (2021-2027). The key factor to drive the market growth is the rise in the need for state-of-art methods and production technologies to improve patient outcomes pertaining to various diseases. For instance, in November 2019, South Africa announced that it is going to introduce state-of-the-art known TLD for HIV treatment as almost 20% of the people globally who have HIV live in South Africa. This introduction of the new treatment to have a significant impact on global HIV response and contributes to reaching UN goals for ending the HIV epidemic in 2030.
To Request a Sample of our Report on Pharmaceutical Contract Manufacturing Market: https://www.omrglobal.com/request-sample/pharmaceutical-contract-manufacturing-market
Rising acquisitions, product
approval, collaborations among the major players in the market also propel the
growth of the market. For instance, in February 2020, Catalent Inc involved in
manufacturing and delivering drugs, biologics, cell and gene therapies
announced that it has signed an agreement with Zumutor Biologics Inc to
manufacture Zumutors ZM008 for the treatment of solid tumours. This agreement
Catalent Biologics will provide process optimization and drug substance
manufacturing services from its facility site in Madison, Wisconsin. Therefore,
with the help of this partnership, Catalent will be supporting Zumutors
clinical development and commercial needs by bringing upon improvements in
cancer treatments. Further, in December 2019, Thermo Fishers Inc officially
opened its latest Viral Vector Contract development and manufacturing
organization in Lexington that cost $90 million. This 50,000 sq. ft facility
will be supporting, the production, testing and manufacturing of viral vectors
that are essential for the advancement of new life-saving gene and cell
therapies.
A full
Report of Pharmaceutical Contract Manufacturing Market is Available
at: https://www.omrglobal.com/industry-reports/pharmaceutical-contract-manufacturing-market
·
The
market number available for – 2020-2027
·
Base
year- 2020
·
Forecast
period- 2021-2027
Segment
Covered-
·
ByCategory
·
By Type
·
By
Product
·
By
Service
Regions
Covered-
·
North
America
·
Europe
·
Asia-Pacific
·
Rest of
the World
Competitive
Landscape- Baxter International Inc, Pfizer Inc., Boehringer Ingelheim
International GmbH., Amgen Inc.
Key questions
addressed by the report
·
What is
the market growth rate?
·
Which
segment and region dominate the market in the base year?
·
Which
segment and region will project the fastest growth in the market?
·
How
COVID-19 impacted the market?
o Deviation from the pre-COVID-19
forecast
o Most affected region and segment
·
Who is
the leader in the market?
·
How
players are addressing challenges to sustain growth?
·
Where
is the investment opportunity?
Global
Pharmaceutical Contract Manufacturing Market Report Segment
·
Human-Based
Drugs
·
Animals
Based Drugs
By Type
·
Sterile
Manufacturing
·
Non-Sterile
Manufacturing
By
Product
·
Over-The-Counter
(OTC) Drugs
·
Active
Pharmaceutical Ingredients (API)
·
Finished
Dosage Formulation
·
Others
(nutritional products and packaging)
By
Services
·
Manufacturing
Services
·
Non-Clinical
Services
·
Research
and Development
Global
Pharmaceutical Contract Manufacturing Market Report Segment by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
Rest of APAC
Rest of The World
·
Latin
America
·
Middle
East & Africa
Company
Profiles
·
Aenova
Holding GmbH
·
Ajinomoto
Co., Inc.
·
Almac
Group Ltd.
·
Amgen Inc.
·
Aurobindo
Pharma Ltd.
·
Baxter
International Inc.
·
BDR
Pharmaceuticals International Pvt. Ltd.
·
BiologicsMD,
Inc.
·
Boehringer
Ingelheim International GmbH
·
Cadence
Inc.
·
Chunghwa
Chemical & Pharmaceutical Co., Ltd.
·
Ciron
Drugs & Pharmaceuticals Pvt. Ltd.
·
Confab
Laboratories Inc.
·
Daito
Pharmaceutical Co., Ltd.
·
Eli
Lilly And Co.
·
F.
Hoffmann-La Roche Ltd.
·
GlaxoSmithKline
PLC
·
Hisamitsu
Pharmaceutical Co., Inc.,
·
Ligand
Pharmaceuticals, Inc.
·
Merck
& Co., Inc.
·
Novartis
International AG
·
Outlook
Therapeutics, Inc.
·
Pfizer
Inc.
·
PhytoHealth
Corp.
·
Piramal
Enterprises Ltd.
·
Procter
& Gamble Co.
·
Radius
Health Inc.
·
Sanofi
S.A.
·
Tarsa
Therapeutics, Inc.
Teva
Pharmaceuticals Industries Ltd.
Reasons for Buying from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/pharmaceutical-contract-manufacturing-market
About Orion
Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market
Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment